Skip to main content
Mark K. Dodson
( out of 25 reviews )

Mark K. Dodson, MD

Languages spoken: English

Clinical Locations

OB-Gyn Avenues Clinic

University of Utah Health Care Avenues Clinic
Salt Lake City
801-587-2809
  • Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 11, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dodson is a phenomenal doctor. He has always answered any questions that I might have regarding my care. He is very personable and anyone can relate to him. Great care from a great doctor.

    April 11, 2024
    HUNTSMAN CANCER CENTER

    Mark Dodson es un doctor con una enorme paciencia y te explica todo con detalle, se preocupa por ti y se toma todo el tiempo necesario para contestar tus preguntas! Es Genial!

    April 10, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dodson is extremely knowledgeable and personable. He takes time to explain and patiently answers questions. I've recommended a friend to him and she was grateful she ended up with him as her doctor. I highly recommend him.

    April 10, 2024
    HUNTSMAN CANCER CENTER

    Amazing Doctor

    April 10, 2024
    HUNTSMAN CANCER CENTER

    Doctor Dodson has always been a great doctor. He has gotten me through a huge surgery with a great team and has always taken good care of me during following visits.

    March 14, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dodson has saved my life multiple times. He genuinely cares for me. This is evident by the questions he ask and the concern he has to make sure I'm doing okay, mentally and physically. He is also and excellent surgeon and is meticulous when operating. Can't say enough great things about him!!

    February 18, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dodson is the best! He remembers everything about my medical history and my previous appointments. He listens, gives helpful advice, and always provides useful information. Professional, knowledgeable, and personable. A great doctor!

    December 13, 2023
    HUNTSMAN CANCER CENTER

    Dr. Mark Dodson is a great doctor.

    July 13, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Dodson is extremely thorough, understanding and attentive. He explains everything in easy to understand language and makes me feel comfortable during during this stressful time.

  • Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Gynecological Oncology

    Education history

    Fellowship Gynecolgic Oncology - Mayo Clinic Fellow
    OB/GYN - University of Mississippi Resident
    Internship OB/GYN - Charity Hospital of Louisiana Intern
    Medicine - East Tennessee State University M.D.
    Undergraduate Biology - Middle Tennessee State University B.S.

    Selected Publications

    Journal Article

    1. Baker WD, Soisson AP, Dodson MK (2013). Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. J Obstet Gynaecol Res, 39(4), 876-78.
    2. Dorais J, Dodson MK, Calvert J, Mize B, Travarelli J, Jasperson K, Peterson CM, Soisson AP (2011 Jul). Fertility-sparing management of endometrial adenocarcinoma. Obstet Gynecol Surv, 66(7), 443-51.
    3. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol, 32(4), 411-6. (Read full article)
    4. Macdonald OK, Sause WT, Lee RJ, Lee CM, Dodson MK, Zempolich K, Gaffney DK (2006). Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol, 103(2), 661-6. (Read full article)
    5. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12(1), 250-6. (Read full article)
    6. Macdonald OK, Sause WT, Lee RJ, Dodson MK, Zempolich K, Gaffney DK (2005). Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol Oncol, 99(3), 730-5. (Read full article)
    7. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L (2004). Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res, 10(8), 2681-6. (Read full article)
    8. Orr JW Jr, Montz FJ, Barter J, Schaitzberg SD, Delmore JE, Dodson MK, Gallup D, Yeh KA, Elias EG (2003). Continuous abdominal fascial closure: a randomized controlled trial of poly(L-lactide/glycolide). Gynecol Oncol, 90(2), 342-7. (Read full article)
    9. Sharp HT, Dodson MK, Draper ML, Watts DA, Doucette RC, Hurd WW (2002). Complications associated with optical-access laparoscopic trocars. Obstet Gynecol, 99(4), 553-5. (Read full article)

    Abstract

    1. Cho S, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Janat-Amsbury M (2011). Anticancer drug delivery utilizing a mucoadhesive hybrid gel for loco-regional gynecologic applications [Abstract]. 102nd annual meeting of American Association of Cancer Research, Orlando, FL.
    2. Janat-Amsbury M, Kablitz C, Gupta K, Soisson A, Peterson C, Dodson MK (2010). Nanoparticle-loaded mucoadhesviehydrogels for the local treatment of cervical cancer [Abstract]. 41st annual meeting of the society of Gynecologic Oncologists.
    3. Dodson MK, Belnap T, Sause W, Soisson A (2010). Inappropriate use of human papillomavirus testing aat time of routine Pap [Abstract]. 41st annual meeting of the Society of Gynecologic Oncologists.
    4. Soisson A, Dodson MK, Webb J, Moore H, Hunn J, Donaldson C, Belnap T, Wendt L, Alleman K, Sause W (2010). Surgical outcomes in women with endometrial carcinoma undergoing hysterectomy by a gynecoloist at a community hospital [Abstract]. 41st annual meeting of the Society of gynecologic Oncologists.
    5. Moore H, Soisson A, Dodson MK, Rowe K, Cannon-Albright L (2010). Familial clustering of endometrial cancer in a well defined population [Abstract]. 41st annual meeting of the Society of Gynecologic Oncologists.
    6. Pittman JH, Soisson AP, Dodson MK, Hunn JR, Moore H, Webb J, Soisson E, Belnap T, Alleman K, Sause W, Janat-Amsbury M (2010). Accuracy of surgical assessment of myometrial invasion in women with endometrial cancer [Abstract]. 39th Annual meeting of the Western Association of Gynecologic Oncologists, Santa Barbara, CA.
    7. Hunn J, Soisson AP, Dodson MK (2009). The immunostimulant keyhole limpet hemocyanin inhibits cervical cancer cell growth in-vitro via apoptosis and DNA double strand breaks [Abstract]. 38th annual meeting of the Western Association of Gynecologic Oncologists, Vancouver, Canada.
    8. Soisson AP, Dodson MK (2008). Differences in surgical procedures between general gynecologists and gynecologic oncologists for women with endometrial cancer [Abstract]. 36th annual meeting of the Society of Gynecologic Oncologists, Sunriver Resort, Oregon.
    9. Soisson EE, Soisson AP, Kulgren R, Dodson MK, Zempolich K, Sause W, Gaffney D, Rowe K, Alleman K, Pinto K (2007). insufficient surgical staging by general gynecologists compared to gynecologic oncologists for women with endometrial cancer [Abstract]. 36th annual meeting of the Western Association of Gynecologic Oncologists, Lake Tahoe, CA.
    10. Soisson E, Soisson AP, Zempolich K, Dodson MK, Sause W, Gaffney D, Horvath E (2006). An analysis of differences in care for women with endometrial adenocarcinoma: Surgical care by general gynecologists in the community compared to gynecologic oncologists at tertiary medical centers: Preliminary information [Abstract]. Western Association of Gynecologic Oncologists, Lake Tahoe, CA.
  • News & Podcasts